Alaunos Therapeutics, Inc. Other Additional Capital
Alaunos Therapeutics, Inc. (TCRT) had Other Additional Capital of $3.54 million as of 2014-06-30, per its 10-Q filed 2014-08-07.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:OtherAdditionalCapital · last filed 2015-02-26
- 2014-06-30: Other Additional Capital $3.54M.
- 2014-03-31: Other Additional Capital $3.60M.
- 2013-12-31: Other Additional Capital $3.60M.
- 2013-09-30: Other Additional Capital $3.66M.
| Period end | Other Additional Capital |
|---|---|
| 2014-06-30 | $3.54M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $3.60M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $3.60M 10-K · filed 2015-02-26 |
| 2013-09-30 | $3.66M 10-Q · filed 2013-10-22 |
| 2013-06-30 | $3.73M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $6.84M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $6.91M 10-K · filed 2014-03-03 |
| 2012-09-30 | $6.91M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $7.01M 10-Q/A · filed 2012-08-28 |
| 2012-03-31 | $7.08M 10-Q · filed 2012-05-03 |
| 2011-12-31 | $12.61M 10-K · filed 2013-03-18 |
| 2011-09-30 | $13.72M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $13.80M 10-Q/A · filed 2011-08-09 |
| 2010-12-31 | $22.79M 10-K · filed 2012-02-29 |
| 2010-09-30 | $22.83M 10-Q · filed 2011-08-01 |
| 2009-12-31 | $23.07M 10-Q · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |